Across TCGA pan-cancer cohorts, TMEM88B mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated TMEM88B data layer compared with 21 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher TMEM88B mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated TMEM88B expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

HNSC and GBM are the cancer types where TMEM88B mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	IV	0.882	0.441	.008	9	view →
GBM	OS	Median	All	0.250	0.537	.033	1	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: TMEM88B tumor-vs-normal RNA expression · all TMEM88B data types